Cranial bone marrow monocytes drive brain injury inflammation and respond to fenofibrate
Targeting PPARα deficiency in cranial bone marrow monocytes improved cognitive function and reduced neurodegeneration markers in older patients with chronic brain injury.
Science translational medicine · Lu Z et al. · Paper published 30 Sep 2026
Studying transgenic animals and older adult patients, researchers investigated whether cranial bone marrow immune cells drive chronic neuroinflammation following traumatic brain injury. They discovered that injury triggered persistent aberrant myelopoiesis in cranial bone marrow, causing an expansion of inflammatory monocytes and macrophages that worsened with aging. These cells migrated into the brain, driving neuroinflammation and neurological deficits. Mechanistically, age-associated deficiency in peroxisome proliferator-activated receptor alpha (PPARα) caused lipid metabolism dysfunction, which altered inflammatory chromatin states via H3K4me3. Activating PPARα with fenofibrate corrected monocyte lipid metabolism and lowered brain infiltration. Furthermore, in a randomized proof-of-concept clinical trial with 40 older adult patients with chronic brain injury, fenofibrate treatment reduced plasma neurofilament light chain levels and improved cognitive functions.
Why it matters
The findings show that age-dependent metabolic defects in the skull bone marrow can actively exacerbate long-term neuroinflammation and neurological decline after brain trauma. Restoring PPARα activity points to a metabolic strategy for protecting the aging brain from persistent immune-mediated damage.
Caveats
The clinical evidence comes from a small, proof-of-concept trial limited to 40 older adults, requiring validation in larger cohorts. In addition, detailed mechanistic and cellular trafficking findings relied on animal assays alongside human clinical specimens.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Cranial bone marrow-derived monocytes promote neuroinflammation in chronic traumatic brain injury
Lu Z, Wang C, Gong P et al.
Science translational medicine · 30 Sep 2026 · Peer-reviewed
- Relevance
- Relevant
- News value
- Important
- Evidence
- Human trial
- Status
- Peer-reviewed
More on Inflammaging
See allSomatic blood mutations associate with accelerated frailty and functional decline in humans
In a preprint analyzing over 730,000 adults, researchers linked clonal hematopoiesis to faster physical decline mediated by T-cell changes.
medRxiv · Zhao K et al.
Impaired glymphatic clearance links inflammation to accelerated brain aging in schizophrenia
Neuroimaging and post-mortem transcriptomics connect disrupted astrocytic aquaporin-4 polarization and blood-brain barrier breakdown to increased epigenetic and brain age.
bioRxiv · Tan X et al.
ASXL1 mutations in clonal hematopoiesis accelerate aortic valve calcification
Large human cohort data and cell experiments show that ASXL1-driven clonal hematopoiesis worsens aortic valve hemodynamics and promotes calcification through inflammatory signaling.
medRxiv · Small A et al.
Loss of SATB1 alters 3D genome architecture in aged mouse T cells
Declining levels of the chromatin organizer SATB1 disrupt genomic boundaries and drive inflammatory gene activation in naive CD4+ T cells.
Science advances · Wang B et al.
Transitional senescent monocytes drive age-related inflammation in humans
Researchers identified a transient senescent-like monocyte state governed by the transcription factor AP-1 that primes cells toward inflammatory and sepsis-associated states.
bioRxiv : the preprint server for biology · Vasilopoulos T et al.